Latest news

Filters (1)
January 8, 2024

Debiopharm Extends SunRock Biopharma Partnership for Antibody-Drug Conjugates Targeting HER3 in EGFR Mutated Cancers

Read more
September 21, 2023

Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers

Read more
September 22, 2022

Big Impact, Small Package: Debiopharm Launches a Wazoku Open-Innovation Challenge for Small Antibody Drug Conjugate Technology

Read more
June 16, 2021

Debiopharm and Ubix Therapeutics launch research to develop a new anti-cancer modality – antibody degraducer® conjugates

Read more
February 25, 2021

Debiopharm and Genome & Company Join Forces to Create New Highly Specific Therapies For Cancer Patients

Read more